How long should patients avoid driving or operating dangerous machinery after Abecma (idecabtagene vicleucel) infusion?

Patients should avoid driving or operating heavy or potentially dangerous machinery for at least 4 weeks after Abecma (idecabtagene vicleucel) infusion, or longer until neurological adverse reactions resolve at the physician’s discretion, because of potential neurological reactions including altered mental status or seizures.